EFFECTIVENESS OF PACLITAXEL-ELUTING BALLOON CATHETER IN PATIENTS WITH CORONARY IN-STENT RESTENOSIS  by Habara, Seiji et al.
    
  i2 SUMMIT   
E1975
JACC April 5, 2011
Volume 57, Issue 14
EFFECTIVENESS OF PACLITAXEL-ELUTING BALLOON CATHETER IN PATIENTS WITH CORONARY IN-STENT 
RESTENOSIS
i2 Poster Contributions
Ernest N. Morial Convention Center, Hall F
Tuesday, April 05, 2011, 9:30 a.m.-10:45 a.m.
Session Title: PCI - Chronic Total Occlusions; Restenosis
Abstract Category: 22. Restenosis/Instent Restenosis - Prevention and Mgt.
Session-Poster Board Number: 2517-598
Authors: Seiji Habara, Kazuaki Mitsudo, Kazushige Kadota, Tsuyoshi Goto, Naoki Oka, Yasushi Fuku, Shingo Hosogi, Hiroyuki Tanaka, Takeshi Tada, 
Yoshikazu Shigemoto, Daiji Hasegawa, Suguru Otsuru, Naoki Saito, Yuki Hayakawa, Kurashiki central hospital, Kurashiki, Japan
Background: Paclitaxel-eluting balloon (PEB) has been shown to be safe and effective in reducing restenosis among patients with bare metal stent 
(BMS) restenosis. However, to our knowledge, there are currently no data to support use of PEB in treating drug-eluting stent restenosis. The aim of 
this study was to investigate the efficacy of PEB (SeQuent® Please) for the treatment of coronary in-stent restenosis lesions.
Methods: Between September 2008 and March 2010, 162 patients with 183 lesions who underwent repeat revascularization with PEBs for 
in-stent restenosis lesions were enrolled (BMS restenosis, n = 32; sirolimus-eluting stent [SES] restenosis, n = 94; paclitaxel-eluting stent [PES] 
restenosis, n = 29; zotarolimus-eluting stent [ZES] restenosis, n = 23). All initial stents were implanted in de novo lesions. Six-month angiographic 
outcomes were compared among the groups.
Results: Figure shows baseline angiographic characteristics and angiographic outcomes. Lesion length was lowest in the SES restenosis group 
compared with the BMS, ZES, and PES groups. At 6-month angiographic follow-up (follow-up rate: 83%), there were no significant differences among 
the groups in late loss, binary restenosis, or target lesion revascularization.
Conclusions: PEB were effective in treating in-stent restenosis lesions. The effectiveness of PEB did not differ between initial stent types. 
